|Year : 2019 | Volume
| Issue : 6 | Page : 227-231
Nationwide seroprevalence, spatial distribution and risk factors of Leishmania in Jordan
Mohammad M Obaidat1, Amira A Roess2
1 Department of Veterinary Pathology and Public Health, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Ar-Ramtha, Irbid 22110, Jordan
2 Department of Global Health, Milken Institute School of Public Health, George Washington University, 950 New Hampshire Ave NW, Washington, DC 20052, USA
|Date of Submission||17-Jan-2019|
|Date of Decision||16-Feb-2019|
|Date of Acceptance||28-May-2019|
|Date of Web Publication||17-Jun-2019|
Mohammad M Obaidat
Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid
Source of Support: This research was supported by Jordan University of Science and Technology
(Deanship of Research Project # 162/2016)., Conflict of Interest: None
Objective: To explore the seroprevalence, spatial distribution and risk factors for Leishmania seropositivity in Jordan.
Methods: Blood samples from 872 apparently healthy participants were randomly selected from 11 governorates in Jordan and tested for anti-Leishmania K39 IgG. Risk factors (animal ownership and agriculture practices) and demographic data were also collected using pre-tested and validated questionnaire.
Results: Overall, 2.52% of participants were seropositive for Leishmania spp. Participants living in the Jordan Valley plateau had significantly greater odds (adjusted odds ratio = 3.70, 95% CI 1.37-9.93) of seropositivity than those living in the Highlands after adjustment for age. Conclusions: This study supports the intermittent reports of cutaneous leishmaniasis outbreaks in the Jordan Valley. Vector control measures in the Jordan Valley should be considered, including insecticide treated bed nets, sugar baits and using flowering plants to attract and trap Phlebotomus papatasi sand flies. Active surveillance in the Jordan Valley is also recommended in light of this and other reports.
Keywords: Zoonotic, Emerging, Pathogens, One Health, Middle East and North Africa
|How to cite this article:|
Obaidat MM, Roess AA. Nationwide seroprevalence, spatial distribution and risk factors of Leishmania in Jordan. Asian Pac J Trop Biomed 2019;9:227-31
|How to cite this URL:|
Obaidat MM, Roess AA. Nationwide seroprevalence, spatial distribution and risk factors of Leishmania in Jordan. Asian Pac J Trop Biomed [serial online] 2019 [cited 2020 Jul 6];9:227-31. Available from: http://www.apjtb.org/text.asp?2019/9/6/227/260394
| 1. Introduction|| |
Leishmania spp. are sandfly-transmitted protozoal pathogens, which are endemic in Latin America, South East Asia, Africa and the Middle East. These pathogens cause two main forms of leishmaniasis; visceral and cutaneous. Visceral leishmaniasis is the most severe form of the disease and manifests as hepatomegaly, severe wasting, and death in 95% of untreated cases,. Cutaneous leishmaniasis typically appears as localized lesions at the sandfly bite location, starting with a pink papule, and then progressing to a nodule or plaque and eventually an ulcer. The ulcer heals spontaneously over a period of several months, but permanent scar may occur.
Approximately 20 species of Leishmania genus can cause leishmaniasis with differences in the distribution and clinical signs of the disease by the causative species. In addition, several sandfly species can transmit the Leishmania parasites; where each sandfly species transmits one Leishmania species. Predominantly, Phlebotomus sandflies act as the biological vector for transmitting Leishmania parasites to humans in Europe, Africa and Asia,. Sandflies become infected from biting an infected mammal. The infected mammals, which become the parasite reservoir, are either animals (zoonotic transmission: such as rodents, foxes, wolves, and dogs) or humans (anthroponotic transmission). In Jordan, Leishmania major causes the most reported cutaneous leishmaniasis, and is transmitted by Phlebotomus papatasi sandfly. Other infections in Jordan are caused by Leishmania tropica, which is transmitted by Phlebotomus sergenti. Visceral leishmaniasis is rare in Jordan and caused by Leishmania infantum. It is believed that the primary reservoirs of Leishmania major are rodents, of Leishmania infantum are dogs and of Leishmania tropica are humans,,,.
Cutaneous leishmaniasis is endemic in several countries around the world. A recent review reported the occurrence of approximately 75% of the worldwide cutaneous leishmaniasis in Syria, Algeria, Ethiopia, Sudan, Iran, Afghanistan, Brazil, Colombia, Peru and Costa Rica. Jordan neighbors cutaneous leishmaniasis endemic countries such as Syria and Iraq and has been hosting hundreds of thousand refugees from endemic countries such as Syria in recent years. In addition, given the presence of known leishmaniasis risk factors in Jordan (poverty, agriculture, contact with animals, sporadic outbreaks, and livestock use), it is important to examine the seroprevalence of infection throughout the country. Though leishmaniasis is endemic in Jordan, there is a lack of data on the seroprevalence, spatial distribution and risk factors specific to the country. Thus, the aims of this study were to determine the seroprevalence of Leishmania K39 antibody among humans in different regions of the country and to identify current risk factors for Leishmania spp. seropositivity in order to ultimately provide recommendations for controlling leishmaniasis in Jordan.
| 2. Materials and methods|| |
2.1. Sample size calculation
The seroprevalence for Leishmania spp. is unknown in Jordan. Based on reports from neighboring countries, we conservatively assumed a prevalence of 2% and calculated a sample size of 872 to detect a (2±1)% prevalence.
2.2. Sampling and description of participants
Sampling the participants was conducted in different regions/ governorates in Jordan between November 2015 and May 2016. Using a list obtained from the Jordanian Ministry of Health, two to six government health centers were selected randomly from each of 11 governorates based on the size of the population in that governorate. There are 12 governorates in Jordan and one, the governorate of Aqaba, was excluded because it is sparsely populated. Sera from healthy relatives of individuals seeking health care at the selected centers were obtained. The study population did not include any Syrian refugees.
2.3. Samples analysis
The SERION classic Leishmania IgG ELISA test (Virion\Serion GmbH, Würzburg, Germany) was used to determine the presence of Leishmania spp. antibodies in the sera samples. The test used inactivated preparation of the kinesin-like protein (K39) for detecting and quantifying Leishmania-IgG antibodies in sera samples. This test has a sensitivity and specificity of >99%, according to the manufacturer, based on testing 203 serum samples from healthy blood donors and patients with suspected leishmaniasis. In addition, assays that use K39 showed high sensitivity and specificity for detecting leishmaniasis,,. The test results were validated and interpreted as recommended by the manufacturer. Briefly, antibody activities of >15 U/mL were considered positive.
2.4. Risk factors data collection
Risk factors (including animal ownership, agricultural practices, drinking water sources and consumption of raw or undercooked foods) and demographic data from each participant were collected using a self-administered, validated and pre-tested Arabic questionnaire. Data collection was granted approval by the Institutional Research Bioethics Committee of Jordan University of Science and Technology (Policy # 7601) and by the Jordanian Ministry of Health that allows sampling at the government health centers.
2.5. Statistical analysis
The questionnaire and laboratory data were entered in Excel sheet (Microsoft, Redmond, WA, USA). Maps were generated using Tableau 10.4 software (Seattle, WA, USA). Descriptive statistics, chi-square tests and unadjusted odds ratios were calculated by Stata version 14.2 (College Station, TX, USA). A poisson regression was also fitted to assess the association between exposures and seropositivity status. The final model included all variables associated with seropositivity at a P-value < 0.05 in the bivariate analysis and variables found to be associated with seropositivity in the literature.
| 3. Results|| |
Most participants live in a house (68.5%) (as opposed to an apartment), consume traditional wild herbs (50.9%), and use filtered water (63.6%). One third of participants has a garden, one quarter grows vegetables, and about a quarter practices agriculture. Animal ownership in the study sample was highest for goats (15.0%), sheep (13.0%), and dogs (9.6%).
[Table 1] shows the unadjusted (univariate analysis) and adjusted odds ratios (AOR) (multivariate analysis) for factors associated with anti-Leishmania spp. K39 seropositivity. Overall, 2.52% (95% CI, 1.67%-3.29%) of tested participants were seropositive for anti-Leishmania IgG. The seroprevalence was higher among females (2.9%) compared to males (2.0%) and among participants with an income less than $750 USD, but these differences were not statistically significant (P > 0.05). Similarly, there were no significant associations between seropositivity and age, education, and living abroad. Animal ownership, household water source, owning a garden were not associated with seropositivity. Among the study sample, those living in the Jordan Valley plateau had significantly higher odds of Leishmania spp. seropositivity (AOR = 3.70, 95% CI 1.37-9.93) compared with those participants living in the Highland governorates [Figure 1].
|Table 1: Seroprevalence, unadjusted and adjusted odds ratios for anti-Leishmania spp. K39 IgG in Jordan, 2015-2016.|
Click here to view
|Figure 1: Seroprevalence of anti-Leishmania spp. K39 IgG by region of Jordan, 2015-2016 (Tableau version 10.4).|
Click here to view
| 4. Discussion|| |
This study reports that the national seroprevalence of Leishmania K39 antibody in Jordan is 2.52% (95% CI, 1.67-3.29%). This low seroprevalence supports a recent finding of a falling burden of cutaneous leishmaniasis in the Middle East and Africa.
Several risk factors for leishmaniasis reported in the literature were not associated with seropositivity in this study. For example, previous studies reported higher prevalence of leishmaniasis among males compared to females,, but our study did not find any significant difference in seropositivity between males and females. The association between age and leishmaniasis has been debated in literature, with some studies reporting higher prevalence/cases among adults (15-40 years old), and others reported higher prevalence/cases among children (<15 years),. Our study found higher seroprevalence as age increases, but this increase was not significant.
Zoonotic and environmental risk factors for contracting leishmaniasis, have been reported such as contact with animals (particularly ruminants and dogs), and traveling to leishmaniasis-endemic areas. Our study found greater odds of seropositivity with traveling abroad, owning goats and cats, but none of these were statistically significant.
There was significant difference in leishmaniasis seropositivity by region of residence in our study, with the highest seroprevalence among participants living in the Jordan Valley plateau. The climate of the Jordan Valley is warm and humid. This humidity is essential for the eggs of sandflies and for the feeding activities of the adult sandflies. Previous studies indicated the association between leishmaniasis incidence with humidity, rainfall and warm temperatures,. Reports also indicated that the primary causative species of leishmaniasis in the Jordan Valley is Leishmania major, the primary reservoir is the desert rodent and the primary vector is Phlebotomus papatasi,.
Iraq, Saudi Arabia, and Syria share borders with Jordan and have high cutaneous leishmaniasis cases. With the Syrian refugee crisis worsening, the trend of cutaneous leishmaniasis cases in Jordan is likely to increase given recent reports of leishmaniasis among Syrian refugee in Turkey and Lebanon,,,.
This is the first study to report seroprevalence, spatial distribution, and risk factors for leishmaniasis in Jordan. In addition, this was a nationally representative study, with participants sampled from throughout the entire country. Based on this and other reports, it is likely the Jordan valley and its neighboring regions that are the foci of leishmaniasis in Jordan. Thus, interventions and public health awareness programs should specifically target this region of the country. Active surveillance of humans and vectors in the Jordan Valley is recommended, along with active surveillance among refugees.
Previous interventions such as sugar baits and local flowering plants were successful at catching Phlebotomus papatasi in Iran and in the Western side of the Dead Sea, so it could be considered to control leishmaniasis in the Jordan Valley area. Insecticide-treated bed nets have been effective at reducing cutaneous leishmaniasis incidence in some countries the Middle East and may also be worth considering in the Jordan Valley.
Conflict of interest statement
The authors declare that they have no conflict of interest.
The authors thank Alaa E. Bani Salman for her support in implementing this study.
This research was supported by Jordan University of Science and Technology (Deanship of Research Project # 162/2016).
| References|| |
Pace D. Leishmaniasis. J Infect
2014; 69(Suppl 1): S10-18.
World Health Organization. Integrating neglected tropical diseases into global health and development: Fourth WHO report on neglected tropical diseases
. Geneva: World Health Organization; 2017.
Karimkhani C, Wanga V, Coffeng LE, Naghavi P, Dellavalle RP, Naghavi M. Global burden of cutaneous leishmaniasis: A cross-sectional analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis
2016; 16(5): 584-591.
Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the Middle East: Incidence and epidemiology. PLoS Negl Trop Dis
2014; 8(10): e3208.
Alemayehu B, Alemayehu M. Leishmaniasis: A review on parasite, vector and reservoir host. Health Sci J
2017; 11(4): 519.
Hussain M, Munir S, Khan TA, Khan A, Ayaz S, Jamal MA, et al. Epidemiology of cutaneous leishmaniasis outbreak, Waziristan, Pakistan. Emerg Infect Dis
2018; 24(1): 159-161.
Du R, Hotez PJ, Al-Salem WS, Acosta-Serrano A. Old World cutaneous leishmaniasis and refugee crises in the Middle East and North Africa. PLoS Negl Trop Dis
2016; 10(5): e0004545.
Saliba EK, Disi AM, Ayed RE, Saleh N, Al-Younes H, Oumeish O, et al. Rodents as reservoir hosts of cutaneous leishmaniasis in Jordan. Ann Trop Med Parasitol
1994; 88(6): 617-622.
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. Plos One
2012; 7(5): e35671.
Al-Salem WS, Pigott DM, Subramaniam K, Haines LR, Kelly-Hope L, Molyneux DH, et al. Cutaneous leishmaniasis and conflict in Syria. Emerg Infect Dis
2016; 22(5): 931-933.
Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions
. John Wiley & Sons; 2013.
Maalej IA, Chenik M, Louzir H, Ben Salah A, Bahloul C, Amri F, et al. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania
antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am J Trop Med Hyg
2003; 68(3): 312-320.
Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? Nature Rev Microbiol
2007; 5(11): 873-882.
Maia Z, Lirio M, Mistro S, Mendes CM, Mehta SR, Badaro R. Comparative study of rK39 Leishmania
antigen for serodiagnosis of visceral leishmaniasis: Systematic review with meta-analysis. PLoS Negl Trop Dis
2012; 6(1): e1484.
Feiz-Haddad MH, Kassiri H, Kasiri N, Panahandeh A, Lotfi M. Prevalence and epidemiologic profile of acute cutaneous leishmaniasis in an endemic focus, Southwestern Iran. J Acute Dis
2015; 4(4): 292-297.
Reithinger R, Mohsen M, Leslie T. Risk factors for anthroponotic cutaneous leishmaniasis at the household level in Kabul, Afghanistan. PLoS Negl Trop Dis
2010; 4(3): e639.
Votypka J, Kasap OE, Volf P, Kodym P, Alten B. Risk factors for cutaneous leishmaniasis in Cukurova region, Turkey. Trans R Soc Trop Med Hyg
2012; 106(3): 186-190.
Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med
2016; 9(10): 925-932.
Tarawneh Q, Kadıo lu M. An analysis of precipitation climatology in Jordan. Theor Appl Climatol
2003; 74(1): 123-136.
Azimi F, Shirian S, Jangjoo S, Ai A, Abbasi T. Impact of climate variability on the occurrence of cutaneous leishmaniasis in Khuzestan Province, southwestern Iran. Geospat Health
2017; 12(1): 478.
Bounoua L, Kahime K, Houti L, Blakey T, Ebi KL, Zhang P, et al. Linking climate to incidence of zoonotic cutaneous leishmaniasis (L. major)
in pre-Saharan North Africa. Int J Environ Res Public Health
2013; 10(8): 3172-3191.
Mosleh IM, Shonian G, Geith E, Al-Jawabreh A, Natsheh L. The Jordanian Mid Jordan Valley is a classic focus of Leishmania major
as revealed by RFLP of 56 isolates and 173 ITS-1-PCR-positive clinical samples. Exp Parasitol
2015; 148: 81-85.
Özkeklikçi A, Karakus M, Ozbel Y, Töz S. The new situation of Cutaneous leishmaniasis after Syrian civil war in Gaziantep city, Southeastern region of Turkey. Acta Trop
2017; 166: 35-38.
Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR. Revisiting leishmaniasis in the time of war: The Syrian conflict and the Lebanese outbreak. Int J Infect Dis
2014; 29: 115-119.
Mockenhaupt FP, Barbre KA, Jensenius M, Larsen CS, Barnett ED, Stauffer W, et al. Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015. Euro Surveill
2016; 21(10): 30160.
Saghafipour A, Vatandoost H, Zahraei-Ramazani AR, Yaghoobi-Ershadi MR, Rassi Y, Shirzadi MR, et al. Bioassay evaluation of residual activity of attractive toxic sugar-treated barrier fence in the control of Phlebotomus papatasi
(Diptera: Psychodidae). J Vector Borne Dis
2016; 53(4): 335-340.
Muller GC, Revay EE, Schlein Y. Relative attraction of the sand fly Phlebotomus papatasi
to local flowering plants in the Dead Sea region. J Vector Ecol
2011; 36(Suppl 1): S187-194.
Gonzalez U, Pinart M, Sinclair D, Firooz A, Enk C, Velez ID, et al. Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev
2015; 8(8): CD008736.